Anthera Pharmaceuticals, Inc.

OTCPK:ANTH Stock Report

Market Cap: US$26.0

Anthera Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

John Thompson

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure7.4yrs
CEO ownershipn/a
Management average tenure8.8yrs
Board average tenure16.3yrs

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has John Thompson's remuneration changed compared to Anthera Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2018n/an/a

-US$25m

Dec 31 2017US$888kUS$460k

-US$29m

Compensation vs Market: Insufficient data to establish whether John's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare John's compensation with company performance.


CEO

John Thompson (56 yo)

7.4yrs

Tenure

US$888,377

Compensation

Mr. John Craig Thompson has been Chief Executive Officer & Director since December 06, 2016 and served as the President of Anthera Pharmaceuticals, Inc. since January 7, 2016. Mr. Thompson served as the Ch...


Leadership Team

NamePositionTenureCompensationOwnership
Paul Truex
Executive Chairman19.7yrsUS$100.00kno data
John Thompson
CEO & Director7.4yrsUS$888.38kno data
May Liu
Senior VP of Finance & Administration and Principal Accounting Officer11yrsUS$592.61kno data
Paul Adams
Senior Vice President of Global Regulatory Affairs and Compliance10.2yrsno datano data
Joshua Caldwell
Chief Liquidating Officer4.7yrsno datano data

8.8yrs

Average Tenure

55yo

Average Age

Experienced Management: ANTH's management team is seasoned and experienced (8.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Paul Truex
Executive Chairman19.7yrsUS$100.00kno data
John Thompson
CEO & Director7.4yrsUS$888.38kno data
Christopher Henney
Independent Director19.1yrsUS$51.50kno data
David Wofsy
Member of Scientific Advisory Board16.3yrsno datano data
David Thompson
Independent Director18.5yrsUS$50.00kno data
Brent Furse
Independent Director8.1yrsUS$56.83kno data
Michael Konstan
Member of Scientific Advisory Boardno datano datano data
Kenneth Kalunian
Member of Scientific Advisory Board16.3yrsno datano data
Philip Sager
Independent Director9.9yrsUS$54.00kno data
Jonathan Barratt
Member of Scientific Advisory Boardno datano datano data
Joan Merrill
Member of Scientific Advisory Boardno datano datano data
Jeffrey Wagener
Member of Scientific Advisory Boardno datano datano data

16.3yrs

Average Tenure

61.5yo

Average Age

Experienced Board: ANTH's board of directors are seasoned and experienced ( 16.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.